Search filters
Termination TerugBetaalRegeling Invega®

Termination TerugBetaalRegeling Invega®

02/12/2019

Invega® is fully reimbursement from the 1st of December 2019. For this reason the co-payment is ended. Expenses from before the...

Specified overview health insurer

Specified overview health insurer

28/11/2019

To consider and process an invoice of a GVS medicine, we need a specified overview of your healthcare costs issued by your health...

Termination TerugBetaalRegeling Fampyra®

Termination TerugBetaalRegeling Fampyra®

08/11/2019

Fampyra® is fully reimbursement from the 1st of September 2019. For this reason the co-payment for Fampyra ended per August 31,...

Launch of TerugBetaalRegeling Veltassa®

Launch of TerugBetaalRegeling Veltassa®

18/09/2019

The health insurer does not fully reimburse Veltassa® 8.4g. The producer of this medicine has therefore asked TBR Nederland to...

Amendment to TerugBetaalRegeling Forxiga® and Xigduo®Amendment to TerugBetaalRegeling Forxiga® and Xigduo®

Amendment to TerugBetaalRegeling Forxiga® and Xigduo®

06/09/2019

The health insurer does not yet reimburse this medication as monotherapy or for specific combination treatment. The producer of...

You are currently offline. Some pages or content may fail to load.